RELIQ HEALTH TECHS INC - RQHTF STOCK NEWS

Reliq Health Technologies Inc. (OTC:RQHTF) has signed contracts with six new clients in the U.S., including three home health agencies and a nephrology practice. The company anticipates onboarding over 3,500 patients by Q1 2022, generating over $50 per patient monthly. CEO Dr. Lisa Crossley noted the iUGO Care platform enhances health outcomes while significantly boosting clinician revenue. Additionally, Michael Frankel has been appointed as the new CFO to aid in consolidating operations and preparing for a NASDAQ uplisting.

Reliq Health Technologies Inc. (OTC:RQHTF) announced that CEO Dr. Lisa Crossley will present at the Global Chinese Financial Forum on November 4, 2021, at 10:25am PDT / 1:25pm EDT. This virtual conference focuses on Small Cap Investing and targets the Chinese investment community in North America, highlighting opportunities across various sectors including healthcare. Reliq's iUGO Care platform enhances home-based patient care, aiming to improve health outcomes and reduce costs. Registration for the event is free, ensuring broad access to potential investors.

Reliq Health Technologies Inc. (RQHTF) announced a significant update on Q1 FY 2022 sales, revealing revenues of over $1.5 million, nearly tripling compared to the previous quarter. This marks Reliq's first full profitable quarter, with expectations to achieve a monthly revenue run rate of $2 million by December 2021. The company anticipates strong growth driven by the expansion of virtual care programs by Medicare. Target margins are set at 75% gross and 45% EBITDA. Overall, the outlook for FY 2022 appears promising as the healthcare market embraces telemedicine solutions.

Reliq Health Technologies Inc. (OTCQB: RQHTF) announced its FY 2021 audited financials, revealing a gross margin increase to 58% from 15% in FY 2020. Despite flat revenues due to the pandemic, Q4 saw a 25% revenue increase compared to Q3. The company anticipates reaching a revenue run rate of $2 million per month by year-end 2021 and achieving 75% gross margins in 2022. Reliq has signed contracts with over 30 new customers and launched new telemedicine solutions, enhancing its growth potential.

Reliq Health Technologies (OTC:RQHTF) has signed contracts with four new US primary care practices to implement its iUGO Care platform for chronic disease management. The CEO, Dr. Lisa Crossley, highlighted the expanding eligibility of Medicare and Medicaid patients for virtual care, leading to increased demand for iUGO Care. Reliq anticipates onboarding over 2,000 patients, generating average revenue of $50 per patient monthly, with completion expected in early 2022. This growth follows a quiet first half of 2021 due to the pandemic.

Reliq Health Technologies Inc. (OTC:RQHTF) has announced collaborations with three new primary care physician practices in Puerto Rico through its partnership with digiiMed. The company will utilize its iUGO Care platform to provide services for chronic disease management, targeting over 3,600 patients. Each patient is expected to generate approximately $40 per month in revenue. Reliq's CEO highlighted the pressing health concerns in Puerto Rico, where many residents are affected by chronic diseases. Onboarding will commence this month and is expected to be finalized by early 2022.

Reliq Health Technologies Inc. (OTC:RQHTF) announced contracts with three new Texas physician practices for its iUGO Care platform, expected to onboard 1,500 patients at an average revenue of $60 USD monthly per patient. This follows new Texas Medicaid guidelines allowing broader reimbursement for remote patient monitoring of chronic conditions, enhancing demand for Reliq's services. The onboarding is set to begin this month and complete by the end of the quarter, as healthcare providers aim to manage chronic diseases proactively amid rising COVID-19 cases.

Reliq Health Technologies Inc. (OTC:RQHTF) will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7. CEO Dr. Lisa Crossley will present updates on the company's growth and take part in a fireside chat on October 5 at 1:15 PM ET. Investors can access a webcast of the presentation on the company's website. Dr. Crossley will also conduct one-on-one meetings throughout the event. Reliq specializes in developing telemedicine solutions, particularly through their iUGO Care platform, aimed at improving healthcare delivery and outcomes.

Reliq Health Technologies has announced new contracts through its partnership with Maxlink Health to provide its iUGO Care platform to three physician practices in Dallas, TX. The company expects to onboard over 1,800 Medicare patients starting this month, generating an average of $40 USD per patient monthly. Reliq forecasts achieving a revenue run rate of approximately $2 Million per month by December 2021, supported by strong market demand. With anticipated gross margins over 75% and EBITDA margins over 45%, Reliq does not expect to require additional funding.